No detection of Helicobacter pylori in atherosclerotic plaques in end stage renal disease patients undergoing kidney transplantation

Indian Journal of Nephrology

Volumn 23, Issue 4, 2013, Pages 259-263

  Ahmadnia, H ^a   Vossoughinia, H ^a   Mansourian, E ^a   Gaffarzadegan, K ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; end stage renal disease; helicobacter pylori; kidney transplantation

Indexed keywords

BACTERIAL DNA; UREASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; DIABETES MELLITUS; ESOPHAGOGASTRODUODENOSCOPY; FAMILY; FEMALE; HELICOBACTER INFECTION; HISTORY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; ILIAC ARTERY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; STOMACH BIOPSY; SURGICAL PATIENT;

EID: 84880713885     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.114483     Document Type: Article

References (43)

1. Novick AC. Atherosclerotic ischemic nephropathy. Epidemiology and clinical considerations. Urol Clin North Am 1994;21:195-200.
2. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-72.
3. Ahmadnia H, Shamsa A, Yarmohammadi A, Darabi M, AslZare M. Kidney transplantation in older adults: Does age affect graft survival? Urol J 2005;2:93-6.
4. Nusair MB, Rajpurohit N, Alpert MA. Chronic Infammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease. Cardiorenal Med 2012;2:117-124.
5. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, et al. Nontraditional risk factors and biomarkers for cardiovascular disease: Mechanistic, research, and clinical considerations for youth: A scientifc statement from the American Heart Association. Circulation 2011;123:2749-69.
6. Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: Ischemia and beyond. Prog Cardiovasc Dis 2009;52:196-203.
7. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-Reactive protein, a sensitive marker of infammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992. Circulation 1999;99:237-42.
8. Luchtefeld M, Grothusen C, Gagalick A, Jagavelu K, Schuett H, Tietge UJ, et al. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation 2010;122:1621-8.
9. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002;105:15-21.
10. Ross R. Atherosclerosis: An infammatory disease. N Engl J Med 1999;340:115-26.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Infammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
12. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
13. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, infammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-25.
14. Tremolada S, Delbue S, Ferraresso M, Carloni C, Elia F, Larocca S, et al. Search for genomic sequences of microbial agents in atherosclerotic plaques. Int J Immunopathol Pharmacol 2011;24:243-6.
15. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726-32.
16. Farsak B, Yildirir A, Akyön Y, Pinar A, Oç M, Böke E, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;38:4408-11.
17. Iriz E, Cirak MY, Engin ED, Zor MH, Erer D, Ozdogan ME, et al. Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsies. Tex Heart Inst J 2008;35:130-5.
18. Park MJ, Choi SH, Kim D, Kang SJ, Chung SJ, Choi SY, et al. Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver 2011;5:321-7.
19. Blum A, Tamir S, Mualem K, Ben-Shushan RS, Keinan-Boker L, Paritsky M. Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects. Am J Med 2011;124:1171-4.
20. Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2006;10:116-23.
21. Gabrielli M, Santoliquido A, Cremonini F, Cicconi V, Candelli M, Serricchio M, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 2004;25:64-8.
22. Makris GC, Makris MC, Wilmot VV, Geroulakos G, Falagas ME. The role of infection in carotid plaque pathogenesis and stability: The clinical evidence. Curr Vasc Pharmacol 2010;8:861-72.
23. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, Brophy J, et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation 2003;107:1966-71.
24. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic infammation: The Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004;96:1470-6.
25. Sotiropoulos A, Gikas A, Skourtis S, Merkouris P, Pentzeridis P, Polydorou A, et al. Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease. Int J Cardiol 2006;109:420-1.
26. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: Role of endothelial dysfunction. Circulation 2002;106:184-90.
27. Wee A, Kang JY, Ho MS, Choong HL, Wu AY, Sutherland IH. Gastroduodenal mucosa in uraemia: Endoscopic and histological correlation and prevalence of helicobacter-like organisms. Gut 1990;31:1093-6.
28. Furuta T, Kaneko E, Suzuki M, Arai H, Futami H. Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments. J Clin Microbiol 1996;34:2421-5.
29. He Q, Wang JP, Osato M, Lachman LB. Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol 2002;40:3720-8.
30. Sugimoto M, Wu JY, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, et al. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol 2009;47:738-42.
31. Weiss J, Tsang TK, Meng X, Zhang H, Kilner E, Wang E, et al. Detection of Helicobacter pylori gastritis by PCR: Correlation with infammation scores and immunohistochemical and CLO test fndings. Am J Clin Pathol 2008;129:89-96.
32. Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis 2009;8:59.
33. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34:2766-9.
34. Blasi F, Ranzi ML, Erba M, Tarsia P, Raccanelli R, Fagetti L, et al. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis 1996;126:339-40.
35. Kaklikkaya I, Kaklikkaya N, Buruk K, Pulathan Z, Koramaz I, Aydin F, et al. Investigation of Chlamydia pneumoniae DNA, chlamydial lipopolisaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease. Cardiovasc Pathol 2006;15:105-9.
36. Dore MP, Sepulveda AR, Bacciu PP, Blasi F, Simula L, Marras L, et al. Detection of Chlamydiaepneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci 2003;48:945-51.
37. Bellomo G, Lippi G, Saronio P, Reboldi G, Verdura C, Timio F, et al. Infammation, infection and cardiovascular events in chronic hemodialysis patients: A prospective study. J Nephrol 2003;16:245-51.
38. AltannavchTs, Roubalová K, Broz J, Hrubá D, Anděl M. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent Eur J Public Health 2003;11:102-6.
39. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: The Busselton Health Study. Eur J Cardiovasc Prev Rehabil 2003;10:278-82.
40. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2004;9:1-6.
41. Kim HL, Jeon HH, Park IY, Choi JM, Kang JS, Min KW. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci 2011;26:654-8.
42. Hoffmeister A, Rothenbacher D, Bode G, Persson K, März W, Nauck MA, et al. Current infection with Helicobacter pylori, but not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with an Atherogenic, Modifed Lipid Profle. Arterioscler Thromb Vasc 2001;21:427-32.
43. Akbas HS, Basyigit S, Suleymanlar I, Kemaloglu D, Koc S, Davran F, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis 2010;9:92.